| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |